Akurath Pharma Llp - Due diligence report

A 360° intelligence report on Akurath Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress sig…

2017-12-01 Bengaluru, Karnataka Strike Off
Share
Connect MCP
AP Akurath Pharma Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Akurath Pharma Llp — 360° Intelligence Report

Generated from MCA filings & public records
65/100
Trust Score
Moderate

Akurath Pharma Llp is assessed as Moderate with a Trust Score of 65/100. Akurath Pharma Llp is a limited liability partnership incorporated in 2017, operating in the Home Appliances sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.

Report generated on 30 Jul 2026 from the latest processed filings. Akurath Pharma Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
65/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 45/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • No balance-sheet filing date on record.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
BANGALORE SHIVARUDRAPPA SMITHA 01234567 Director 01/04/2018 6 yrs Approved
SUNIL KUMAR KADUR VIJAYAKUMAR 01234567 Director 01/04/2018 6 yrs Approved
NANDINI NANJUNDASWAMY 01234567 Director 01/04/2018 6 yrs Approved
KEELARA CHANDRASHEKAR SRIKANTHSHEKAR 01234567 Director 01/04/2018 6 yrs Approved
MEGHANA SHASHI KIRAN 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 65
Growth signals & trust indicators
Operating for 8 years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Adverse company status: Strike Off.
Compliance score is weak (45/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence57/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment55/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view45/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
31 Mar 2018
Last AGM held
Annual general meeting
01 Dec 2017
Incorporated
Registered with Roc Bangalore
Director appointed
BANGALORE SHIVARUDRAPPA SMITHA (Designated Partner)
Director appointed
SUNIL KUMAR KADUR VIJAYAKUMAR (Designated Partner)
Director appointed
NANDINI NANJUNDASWAMY (Designated Partner)
Director appointed
KEELARA CHANDRASHEKAR SRIKANTHSHEKAR (Designated Partner)
Director appointed
MEGHANA SHASHI KIRAN (Designated Partner)
10

Key Observations

Auto-generated from the data above
5 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
Peer companies will appear here as our matching engine processes this industry.
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Akurath Pharma Llp before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Akurath Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Akurath Pharma Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 65/100, distress signals and MSME payment-delay disclosures - know whether Akurath Pharma Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Akurath Pharma Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Akurath Pharma Llp an active company?

Akurath Pharma Llp has MCA status “Strike Off” with a compliance score of 45/100 (Caution Indicated).

Is Akurath Pharma Llp financially healthy?

Processed financial statements are not yet available for Akurath Pharma Llp, so its financial health is unassessed.

Should I do business with Akurath Pharma Llp?

Its overall Trust Score is 65/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Akurath Pharma Llp?

See the directors and ownership sections above for board and shareholding detail. 5 active director(s) are on record.

Does Akurath Pharma Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Akurath Pharma Llp up to date with its ROC filings?

No balance-sheet filing date on record. Overall compliance score: 45/100 (Caution Indicated).

Is it risky to lend to Akurath Pharma Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.